Literature DB >> 19834122

Applicability of BARD score to Japanese patients with NAFLD.

H Fujii, M Enomoto, W Fukushima, A Tamori, H Sakaguchi, N Kawada.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19834122     DOI： 10.1136/gut.2009.182758

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Authors:  Anil Arora; Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

2.  Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan.

Authors:  Yoshio Sumida; Yuichiro Eguchi; Masafumi Ono
Journal:  World J Hepatol       Date:  2010-10-27

3.  A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

Authors:  Yoshio Sumida; Masato Yoneda; Hideyuki Hyogo; Kanji Yamaguchi; Masafumi Ono; Hideki Fujii; Yuichiro Eguchi; Yasuaki Suzuki; Shunsuke Imai; Kazuyuki Kanemasa; Koji Fujita; Kazuaki Chayama; Kohichiroh Yasui; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2010-09-15       Impact factor: 7.527

Review 4.  Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.

Authors:  Jia-Zhen Zhang; Jing-Jing Cai; Yao Yu; Zhi-Gang She; Hongliang Li
Journal:  Gene Expr       Date:  2019-04-22

5.  Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  Joanna Raszeja-Wyszomirska; Barbara Szymanik; Małgorzata Ławniczak; Maciej Kajor; Alina Chwist; Piotr Milkiewicz; Marek Hartleb
Journal:  BMC Gastroenterol       Date:  2010-06-28       Impact factor: 3.067

Review 6.  Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshio Sumida; Atsushi Nakajima; Yoshito Itoh
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

7.  Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.

Authors:  Masato Yoneda; Kento Imajo; Yuichiro Eguchi; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Masafumi Ono; Yasuaki Suzuki; Takumi Kawaguchi; Noriaki Aoki; Michio Sata; Kazuyuki Kanemasa; Yutaka Kohgo; Toshiji Saibara; Kazuaki Chayama; Yoshito Itoh; Toshikazu Yoshikawa; Keizo Anzai; Kazuma Fujimoto; Takeshi Okanoue; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2012-11-27       Impact factor: 7.527

Review 8.  Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Authors:  J K Dowman; J W Tomlinson; P N Newsome
Journal:  Aliment Pharmacol Ther       Date:  2010-12-29       Impact factor: 8.171

9.  Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.

Authors:  Yoshio Sumida; Masato Yoneda; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Hideki Fujii; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Koji Fujita; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  BMC Gastroenterol       Date:  2012-01-05       Impact factor: 3.067

10.  Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease.

Authors:  Akinobu Nakamura; Masato Yoneda; Yoshio Sumida; Yuichiro Eguchi; Hideki Fujii; Hideyuki Hyogo; Masafumi Ono; Yasuaki Suzuki; Takumi Kawaguchi; Noriaki Aoki; Takeshi Okanoue; Atsushi Nakajima; Shin Maeda; Yasuo Terauchi
Journal:  J Diabetes Investig       Date:  2013-05-19       Impact factor: 4.232
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.